品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

covalab/Covalight ECL reagent/1 x (250 ml +15 ml)/opr0009

价格
面议
货号:opr0009
浏览量:127
品牌:covalab
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Datasheet
  • Product description
  • Publications & Images
  • Related products
Product Codeopr0009
ConstituentsReagent Cov A Reagent Cov B
Lysat Type"0
Print datasheet
PrincipleChemiluminescence is defined as the light emitted by a chemical reaction. Horse radish peroxidase (HRP), in the presence of hydrogen peroxide, catalyses the oxidation of a cyclic diacyl hydrazide, such as luminol, to an excited reaction product which on spontaneous change to a stable form emits light. A dramatic increase in the light output can be achieved by the presence of enhancers.
ApplicationsWestern Blot, Dot Blot
RecommendationsChemiluminescence is defined as the light emitted by a chemical reaction. Horse radish peroxydase (HRP), in the presence of hydrogen peroxide, catalyses the oxidation of a cyclic diacyl hydrazide, such as luminol, to an excited reaction product which on s
StorageStored at +4°C
Product typeReagents
Preparation methodTo be used extemporaneously or can be kept at +4°C for few hours : Add 1 drop of oxidant Cov B to 1 mL of substrat Cov A (125 µL of reagent covers 1 cm2 membrane). Detection : Immerse the membrane in Covalight reagent from 1 to 10 minutes. Shake of excess reagent and cover the membrane with a plastic sheet before to exposure.
Print datasheet
* Lassot I et al. Cell Rep. 2018 Nov 27:25(9):2484-2496.e9* LM Bloyet et al.Sci. Adv. 2019, 5 eaaw3702* Lassot I et al. Cell Rep. 2018 Nov 27:25(9):2484-2496* Chapuy-Regaud S et al. Biochimie. 2017 May 5.* Brosse A et al. Nucl. Acids Res. 2016 Jul 20.* Bloyet LM et al. J Virol. 2016 May 11.* Fischer K. TBX3-Mutationsanalysen und Konstruktion einer Zelllinie für TBX2-Inhibitorscreenings. Ph.D. Thesis 2015.* Julien M et al. Biochim Biophys Acta. 2015 Jun 14. pii: S0167-4889(15)00193-7.* Romanets-Korbut O et al. Cell Mol Immunol. 2015 Jun 15.* Couderc C. et al. Mol Cell Endocrinol. 2014 Sep 16. pii:S0303-7207(14)00284-6.* Schnorr S et al. Pain. 2014 Jun:155(6):1079-90.* Brot S, et al. Eur J Neurosci. 2014 Jul 12.* Yakoub S et al. J Cancer Sci Ther 2014, 6.4* Bollard J et al. Neuroendocrinology. 2013 Jan 23.* Perez Alea M et al. Amino Acids. 2013 Jan:44(1):245-50* Chauvelier-Grouiller S. Caractérisation épigénétique du lymphome du manteau. Ph.D. Thesis 2011

Covalight ECL reagent

  • Three differents ECL Reagent were used with an exposure times of 2 min 30.1: Covalight® (opr0009)2: Covalight® Plus (opr1102) 3: Covalight® Xtra (opr1101)">
covalab开发和生产方面拥有20多年的经验。自1995年公司成立以来,我们已成功管理了数千项用于研究,诊断和潜在疗法的多克隆和单克隆抗体开发项目。我们致力于凭借我们的多学科专业知识(免疫学,生物化学,化学),训练有素的科学人员以及与研究人员的紧密合作来致力于科学。我们参与多个国家,欧洲和国际研究计划是我们最大的科学成就之一。我们还提供各种新产品和创新产品,包括抗体和试剂盒。我们的14,000多种抗体目录将帮助您针对癌症,心血管和神经系统疾病(以及其他)针对下一代药物的生物标志物。 Covalab 多克隆和单克隆抗体经过测试可在主要应用中工作,例如Western Blot(WB),免疫组织化学(IHC),免疫细胞化学(ICC),流式细胞仪(FC)和ELISA。浏览超过14,000种针对流行和罕见靶标的一级抗体,涉及主要研究领域:神经科学,癌症,表观遗传学,细胞信号传导等。